Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves' disease
Purpose The first-line antithyroid drug for children and adolescents with Graves' disease (GD) is methimazole (MMI). This study evaluated the relationship between the initial MMI dose and the clinical course of GD after treatment. Methods We studied the efficacy of the initial MMI dose and the...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Korean Society of Pediatric Endocrinology,
2021-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |